{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:11:14Z","timestamp":1794665474449,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670844"],"award-info":[{"award-number":["81670844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160154"],"award-info":[{"award-number":["82160154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["QKH-PTRC-2018-5772-042"],"award-info":[{"award-number":["QKH-PTRC-2018-5772-042"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1004303"],"award-info":[{"award-number":["2018YFC1004303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.intimp.2024.112313","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T02:56:55Z","timestamp":1716865015000},"page":"112313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Unraveling susceptibility genes: A contemporary overview of autoimmune thyroid diseases"],"prefix":"10.1016","volume":"136","author":[{"given":"Wenxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1209-2104","authenticated-orcid":false,"given":"Hongsong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2024.112313_b0005","doi-asserted-by":"crossref","first-page":"572","DOI":"10.5603\/EP.a2021.0076","article-title":"CD4+ cells in autoimmune thyroid disease","volume":"72","author":"Janyga","year":"2021","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.intimp.2024.112313_b0010","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.2147\/JIR.S331579","article-title":"Prevalence and risk factors associated with the occurrence of autoimmune diseases in patients with alopecia areata","volume":"14","author":"Chanprapaph","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2024.112313_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757674","article-title":"The roles of exosomes in immunoregulation and autoimmune thyroid diseases","volume":"12","author":"Zou","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112313_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101387","article-title":"Graves' disease: epidemiology, genetic and environmental risk factors and viruses","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2024.112313_b0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.micpath.2018.01.004","article-title":"Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases","volume":"116","author":"Shukla","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2024.112313_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/979167","article-title":"Immune disorders in Hashimoto's thyroiditis: what do we know so far?","volume":"2015","author":"Pyzik","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112313_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.774362","article-title":"Association between gut microbiota and autoimmune thyroid disease: a systematic review and meta-analysis","volume":"12","author":"Gong","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112313_b0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3803\/EnM.2018.33.2.175","article-title":"Genome-wide association studies of autoimmune thyroid diseases, thyroid function, and thyroid cancer","volume":"33","author":"Hwangbo","year":"2018","journal-title":"Endocrinology and Metabolism (Seoul, Korea)"},{"issue":"7","key":"10.1016\/j.intimp.2024.112313_b0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/thy.2010.1644","article-title":"Genetic susceptibility to autoimmune thyroid disease: past, present, and future","volume":"20","author":"Tomer","year":"2010","journal-title":"Thyroid Off. J. American Thyroid Assoc."},{"issue":"4","key":"10.1016\/j.intimp.2024.112313_b0055","doi-asserted-by":"crossref","first-page":"e0154394","DOI":"10.1371\/journal.pone.0154394","article-title":"Association of cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene polymorphisms with autoimmune thyroid disease in children and adults: case-control study","volume":"11","author":"Ting","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2024.112313_b0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7555\/JBR.30.20140144","article-title":"Association between TSHR gene polymorphism and the risk of Graves' disease: a meta-analysis","volume":"30","author":"Qian","year":"2016","journal-title":"J. Biomed. Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112313_b0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08916934.2018.1486824","article-title":"Analysis of chosen polymorphisms rs2476601 a\/G - PTPN22, rs1990760 C\/T - IFIH1, rs179247 a\/G - TSHR in pathogenesis of autoimmune thyroid diseases in children","volume":"51","author":"Rydzewska","year":"2018","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2024.112313_b0070","doi-asserted-by":"crossref","first-page":"30356","DOI":"10.1038\/srep30356","article-title":"Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: a meta-analysis","volume":"6","author":"Xiong","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.112313_b0075","first-page":"1","article-title":"Polymorphisms in TSHR gene and the risk and prognosis of autoimmune thyroid disease in Tunisian population","volume":"16","author":"Zaaber","year":"2005","journal-title":"Acta endocrinologica (Bucharest Romania: 2005)"},{"key":"10.1016\/j.intimp.2024.112313_b0080","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2147\/OPTH.S136070","article-title":"Single nucleotide polymorphism 1623 A\/G (rs180195) in the promoter of the Thyroglobulin gene is associated with autoimmune thyroid disease but not with thyroid ophthalmopathy","volume":"11","author":"Lahooti","year":"2017","journal-title":"Clin. Ophthalmol. (AucklandN.Z.)"},{"issue":"6","key":"10.1016\/j.intimp.2024.112313_b0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/08916934.2017.1344971","article-title":"Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease","volume":"50","author":"Mizuma","year":"2017","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.intimp.2024.112313_b0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41435-018-0042-z","article-title":"Association between thyroglobulin polymorphisms and autoimmune thyroid disease: a systematic review and meta-analysis of case-control studies","volume":"20","author":"Zhang","year":"2019","journal-title":"Genes Immun."},{"issue":"7","key":"10.1016\/j.intimp.2024.112313_b0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/138920207783591690","article-title":"The HLA region and autoimmune disease: associations and mechanisms of action","volume":"8","author":"Gough","year":"2007","journal-title":"Curr. Genomics"},{"issue":"8","key":"10.1016\/j.intimp.2024.112313_b0100","doi-asserted-by":"crossref","first-page":"e0220858","DOI":"10.1371\/journal.pone.0220858","article-title":"Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study","volume":"14","author":"Tashiro","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112313_b0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.gene.2017.11.057","article-title":"Interaction of HLA-DRB1* alleles and CTLA4 (+49 AG) gene polymorphism in Autoimmune Thyroid Disease","volume":"642","author":"Ramgopal","year":"2018","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.intimp.2024.112313_b0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41435-017-0008-6","article-title":"Critical amino acid variations in HLA-DQB1* molecules confers susceptibility to Autoimmune Thyroid Disease in south India","volume":"20","author":"Ramgopal","year":"2019","journal-title":"Genes and Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2024.112313_b0115","first-page":"223","article-title":"Association of human leukocyte antigens class I and II with Graves' disease in iranian population","volume":"14","author":"Mehraji","year":"2017","journal-title":"Iran. J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112313_b0120","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/bjophthalmol-2020-317091","article-title":"Human leucocyte antigen alleles confer susceptibility and progression to Graves' ophthalmopathy in a Southern Chinese population","volume":"105","author":"Huang","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.intimp.2024.112313_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.761077","article-title":"Recurrence of graves' disease: what genetics of HLA and PTPN22 can tell us","volume":"12","author":"Vejrazkova","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.intimp.2024.112313_b0130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"issue":"Suppl.","key":"10.1016\/j.intimp.2024.112313_b0135","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0092-8674(02)00696-7","article-title":"Genetic control of MHC class II expression","volume":"109","author":"Ting","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112313_b0140","doi-asserted-by":"crossref","first-page":"6839634","DOI":"10.1155\/2022\/6839634","article-title":"HLA-DRA gene polymorphisms are associated with graves' disease as an autoimmune thyroid disease","volume":"2022","author":"Du","year":"2022","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2024.112313_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.103995","article-title":"A significant association of the CTLA4 gene variants with the risk of autoimmune Graves' disease in ethnic Kashmiri population","volume":"347","author":"Shehjar","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2024.112313_b0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.gene.2018.06.023","article-title":"Association of FoxP3 promoter polymorphisms with the risk of Graves' disease in ethnic Kashmiri population","volume":"672","author":"Shehjar","year":"2018","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.intimp.2024.112313_b0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4183\/aeb.2019.423","article-title":"Association of FOXP3 gene variants with risk of Hashimoto's thyroiditis and correlation with anti-TPO antibody levels","volume":"15","author":"Kalantar","year":"2019","journal-title":"Acta Endocrinol. (Buchar)"},{"issue":"3","key":"10.1016\/j.intimp.2024.112313_b0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12020-019-01859-3","article-title":"Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease","volume":"64","author":"Fathima","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.intimp.2024.112313_b0165","doi-asserted-by":"crossref","unstructured":"D.J. L\u00f3pez-Cano, D. Cadena-Sandoval, O. Beltr\u00e1n-Ram\u00edrez, R.E. Barbosa-Cobos, F. S\u00e1nchez-Mu\u00f1oz, L.M. Amezcua-Guerra, Y. Ju\u00e1rez-Vicu\u00f1a, M.C. Aguilera-Cartas, J. Moreno, J. Bautista-Olvera, G. Valencia-Pacheco, R.F. L\u00f3pez-Villanueva, J. Ram\u00edrez-Bello, The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population, Inflammation research : official journal of the European Histamine Research Society... [et al.] 66(9) (2017) 775-781. doi: 10.1007\/s00011-017-1056-0.","DOI":"10.1007\/s00011-017-1056-0"},{"issue":"3","key":"10.1016\/j.intimp.2024.112313_b0170","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4049\/jimmunol.2000708","article-title":"Overexpression of the PTPN22 autoimmune risk variant LYP-620W fails to restrain human CD4(+) T cell activation","volume":"207","author":"Perry","year":"2021","journal-title":"J. Immunol. (Baltimore, Md. 1950)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112313_b0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12020-020-02337-x","article-title":"Polymorphisms of the genes CTLA4, PTPN22, CD40, and PPARG and their roles in Graves' disease: susceptibility and clinical features","volume":"71","author":"Bufalo","year":"2021","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.intimp.2024.112313_b0180","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180143","article-title":"Association of TNF-\u03b1 promoter polymorphism and Graves' disease: an updated systematic review and meta-analysis","volume":"38","author":"Tu","year":"2018","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2024.112313_b0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40618-020-01300-x","article-title":"Gene polymorphisms of pro-inflammatory cytokines may affect the risk of Graves' disease: a meta-analysis","volume":"44","author":"Zhu","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.intimp.2024.112313_b0190","doi-asserted-by":"crossref","unstructured":"X.Q. Shao, X.L. Ding, K. Mu, X. Wang, X.F. An, Q.M. Yao, L. Li, Q. Li, R.H. Song, S.T. He, J. Xu, J.A. Zhang, Associations of TNFRSF1A Polymorphisms with Autoimmune Thyroid Diseases: A Case-Control Study, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 50(2) (2018) 117-123. doi: 10.1055\/s-0043-124435.","DOI":"10.1055\/s-0043-124435"},{"issue":"7","key":"10.1016\/j.intimp.2024.112313_b0195","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/02713683.2019.1705494","article-title":"TNFSF15 polymorphisms are associated with graves' disease and graves' ophthalmopathy in a han chinese population","volume":"45","author":"Zhang","year":"2020","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.intimp.2024.112313_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.544658","article-title":"Analysis of polymorphisms rs7093069-IL-2RA, rs7138803-FAIM2, and rs1748033-PADI4 in the group of adolescents with autoimmune thyroid diseases","volume":"11","author":"Sawicka","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.intimp.2024.112313_b0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1507\/endocrj.EJ19-0480","article-title":"Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively","volume":"67","author":"Okamoto","year":"2020","journal-title":"Endocr. J."},{"issue":"4","key":"10.1016\/j.intimp.2024.112313_b0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/08916934.2016.1151005","article-title":"Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases","volume":"49","author":"Zaaber","year":"2016","journal-title":"Autoimmunity"},{"issue":"7","key":"10.1016\/j.intimp.2024.112313_b0215","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jmedgenet-2013-101595","article-title":"An X chromosome-wide association analysis identifies variants in GPR174 as a risk factor for Graves' disease","volume":"50","author":"Chu","year":"2013","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.intimp.2024.112313_b0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.190.2.217","article-title":"ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes","volume":"190","author":"Kirchner","year":"1999","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.intimp.2024.112313_b0225","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1093\/hmg\/ddt183","article-title":"Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis","volume":"22","author":"Zhao","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.intimp.2024.112313_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/genes11080858","article-title":"GPR174 and ITM2A gene polymorphisms rs3827440 and rs5912838 on the X chromosome in Korean Children with Autoimmune Thyroid Disease","volume":"11","author":"Cho","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.intimp.2024.112313_b0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.14196\/mjiri.32.4","article-title":"The association of FokI and ApaI polymorphisms in vitamin D receptor gene with autoimmune thyroid diseases in the northwest of Iran","volume":"32","author":"Zarrin","year":"2018","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"6","key":"10.1016\/j.intimp.2024.112313_b0240","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ando.2015.01.003","article-title":"Genetic susceptibility to autoimmune thyroid diseases in a Chinese Han population: Role of vitamin D receptor gene polymorphisms","volume":"76","author":"Meng","year":"2015","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.intimp.2024.112313_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145750","article-title":"The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population","volume":"793","author":"Zhou","year":"2021","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.intimp.2024.112313_b0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2478\/bjmg-2020-0011","article-title":"Implication of VDR Rs7975232 and FCGR2A Rs1801274 gene polymorphisms in the risk and the prognosis of autoimmune thyroid diseases in the Tunisian population","volume":"23","author":"Mestiri","year":"2020","journal-title":"Balkan J. Med. Genet."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:45:21Z","timestamp":1791301521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924008336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":49,"alternative-id":["S1567576924008336"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112313","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling susceptibility genes: A contemporary overview of autoimmune thyroid diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112313"}}